Aurelius Health Group review
Aurelius markets clinician-monitored, compounded tirzepatide microdosing. Its promised check-ins are distinct from the evidence needed to support its broader wellness claims.
The verdict
Aurelius is a microdose service, so it should not be treated as equivalent to a conventional obesity-treatment program. The site describes physician contact and monthly monitoring, but claims about muscle retention, nausea and metabolic benefits need stronger context than a branded-drug trial or a testimonial.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Tirzepatide
- Form
- Injection
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Aurelius Health Group offers a compounded GLP-1 microdose protocol, with optional formulations involving other ingredients. The homepage presents it as clinician-guided metabolic care. Readers seeking standard-dose weight-loss treatment should establish whether that is actually offered before enrolling.
Who writes the prescription, and what do they see?
The offer describes review by board-certified MD or DO physicians. Its terms distinguish independent professional judgment from the platform’s administrative role. A review-speed claim does not establish that an individual patient should receive tirzepatide.
Monthly physician check-ins, adjustments and secure messaging are included in the advertised subscription. Ask whether a visit is live or asynchronous, how urgent symptoms are handled and which medical conditions would prompt a referral instead of online treatment.
What happens when the dose goes up?
The service emphasizes physician-directed microdosing and adjustment. That approach is not interchangeable with the regimens studied in major obesity trials. Ask the clinician what evidence supports your proposed dose and how response, adverse effects and discontinuation will be assessed.
What the price includes
The homepage separates a reduced first month from a continuing monthly subscription covering physician care, the protocol and monitoring. Those are microdose-plan terms, not evidence of a comparable full-dose medication price. Confirm any changes for a different prescribed preparation.
What it claims, and what it cites
The advertised protocol is compounded tirzepatide. Additional ingredients are named in the broader protocol description; confirm the exact prescription instead of assuming every order contains the same mixture. Compounded products are not FDA approved, and their quality is not established by branded-product trial outcomes.
Where it holds up, and where it does not
- Strength: Physician check-ins included in the offer
- Strength: Secure clinical messaging described
- Strength: Introductory and continuing periods distinguished
- Limitation: Microdose outcomes require separate evidence
- Limitation: Protocol may include additional ingredients
- Limitation: Not a substitute for standard-dose trial evidence
What the evidence says about this kind of treatment
The assessment above is about Aurelius Health Group. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- Someone specifically discussing microdose tirzepatide with a clinician and prepared to examine the evidence and alternatives.
- Wrong for
- A patient seeking an FDA-approved weight-loss brand or assuming microdosing delivers conventional obesity-trial results.
The evidence behind what Aurelius Health Group prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Aurelius Health Group compares
| Seller | Who it suits | Go |
|---|---|---|
| SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | See SkinnyRx → |
| ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | See ShedRx → |
| RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | See RxSpan MD → |
More GLP-1 telehealth sellers reviews: Iron Med RXiThriveMDIvim HealthIvologistIvy RxJently
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is Aurelius a standard-dose weight-loss plan?
- The reviewed homepage centers on microdosing. Confirm the actual prescribed regimen and available alternatives.
- Does a named pharmacy list identify my prescription?
- No. The terms name possible partner pharmacies, but the individual prescription should identify the actual dispenser and ingredients.
Sources for this review
Provider information checked . Terms can change.